7
Views
0
CrossRef citations to date
0
Altmetric
Original Research

The MIF -173G/C polymorphism and risk of coal workers' pneumoconiosis in a Chinese population

, , , , , , , & show all
Pages 37-42 | Published online: 14 May 2012

References

  • Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3(10):791–800.
  • Schober A, Bernhagen J, Weber C. Chemokine-like functions of MIF in atherosclerosis. J Mol Med (Berl). 2008;86(7):761–770.
  • Lue H, Dewor M, Leng L, Bucala R, Bernhagen J. Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell Signal. 2011;23(1):135–144.
  • Heinrichs D, Knauel M, Offermanns C, et al. Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74. Proc Natl Acad Sci U S A. 2011;1a08(42):17444–17449.
  • Liu L, Ji C, Chen J, et al. A global genomic view of MIF knockdownmediated cell cycle arrest. Cell Cycle. 2008;7(11):1678–1692.
  • Takahashi A, Iwabuchi K, Suzuki M, Ogasawara K, Nishihira J, Onoe K. Antisense macrophage migration inhibitory factor (MIF) prevents anti-IgM mediated growth arrest and apoptosis of a murine B cell line by regulating cell cycle progression. Microbiol Immunol. 1999;43(1):61–67.
  • Plant BJ, Gallagher CG, Bucala R, et al. Cystic fibrosis, disease severity and a macrophage migration inhibitory factor polymorphism. Am J Respir Crit Care Med. 2005;172(11):1412–1415.
  • Bargagli E, Olivieri C, Nikiforakis N, et al. Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis. Respir Physiol Neurobiol. 2009;167(3):261–267.
  • Denz A, Pilarsky C, Muth D, Ruckert F, Saeger HD, Grutzmann R. Inhibition of MIF leads to cell cycle arrest and apoptosis in pancreatic cancer cells. J Surg Res. 2010;160(1):29–34.
  • Rimal B, Greenberg AK, Rom WN. Basic pathogenetic mechanisms in silicosis: current understanding. Curr Opin Pulm Med. 2005;11(2):169–173.
  • Fujimura N. Pathology and pathophysiology of pneumoconiosis. Curr Opin Pulm Med. 2000;6(2):140–144.
  • Fukuda Y, Ishizaki M, Masuda Y, Kimura G, Kawanami O, Masugi Y The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am J Pathol. 1987;126(1):171–182.
  • Danila E, Sileikiene V, Nargela R, Zurauskas E, Loskutoviene G. Different course of silicosis in four brothers of one family. Int J Occup Med Environ Health. 2009;22(1):51–57.
  • Song Z, Qian H, Wang S, Jia X, Ye Y, Ni C. The incidences of CWP in Xuzhou coal mines from 2003 to 2008. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2011;29(1):61–63.
  • Kudrin A, Ray D. Cunning factor: macrophage migration inhibitory factor as a redox-regulated target. Immunol Cell Biol. 2008;86(3):232–238.
  • Lai KN, Leung JC, Metz CN, Lai FM, Bucala R, Lan HY. Role for macrophage migration inhibitory factor in acute respiratory distress syndrome. J Pathol. 2003;199(4):496–508.
  • De Benedetti F, Meazza C, Vivarelli M, et al. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2003;48(5):1398–1407.
  • Donn R, Alourfi Z, De Benedetti F, et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46(9):2402–2409.
  • Vivarelli M, D’Urbano LE, Insalaco A, et al. Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids. Clin Exp Rheumatol. 2007;25(5):775–781.
  • Makhija R, Kingsnorth A, Demaine A. Gene polymorphisms of the macrophage migration inhibitory factor and acute pancreatitis. JOP. 2007;8(3):289–295.
  • Nohara H, Okayama N, Inoue N, et al. Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol. 2004;39(3):242–246.
  • Plant BJ, Ghani S, O’Mahony MJ, et al. Sarcoidosis and MIF gene polymorphism: a case-control study in an Irish population. Eur Respir J. 2007;29(2):325–329.
  • Wang M, Ye Y, Qian H, et al. Common genetic variants in pre-microRNAs are associated with risk of coal workers’ pneumoconiosis. J Hum Genet. 2010;55(1):13–17.
  • Wang M, Wang S, Song Z, et al. Associations of IL-4, IL-4R, and IL-13 gene polymorphisms in coal workers’ pneumoconiosis in China: a case-control study. PLoS One. 2011;6(8):e22624.
  • Castranova V Vallyathan V Silicosis and coal workers’ pneumoconiosis. Environ Health Perspect. 2000;108 Suppl 4:675–684.
  • Yucesoy B, Vallyathan V, Landsittel DP, Simeonova P, Luster MI. Cytokine polymorphisms in silicosis and other pneumoconioses. Mol Cell Biochem. 2002;234–235(1–2):219–224.
  • Zhai R, Liu G, Ge X, et al. Genetic polymorphisms of MnSOD, GSTM1, GSTT1, and OGG1 in coal workers’ pneumoconiosis. J Occup Environ Med. 2002;44(4):372–377.
  • Yao W, Wang ZM, Wang MZ, Hao CF, Wang N. The relationship between the concentration of TGF-beta1 in serum and its gene polymorphisms in CWP. Sichuan Da Xue Xue Bao Yi Xue Ban. 2005;36(6):827–829.
  • Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science. 2002;296(5567):490–494.
  • Sevketoglu E, Yilmaz A, Gedikbasi A, et al. Urinary macrophage migration inhibitory factor in children with urinary tract infection. Pediatr Nephrol. 2009;25(2):299–304.
  • Otukesh H, Fereshtehnejad SM, Hoseini R, et al. Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis. Pediatr Nephrol. 2009;24(1):105–111.
  • Yende S, Angus DC, Kong L, et al. The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia. Faseb J. 2009;23(8):2403–2411.
  • Shiroeda H, Tahara T, Nakamura M, et al. Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan. Cytokine. 2010;51(2):173–177.
  • Donn RP, Shelley E, Ollier WE, Thomson W. A novel 5/-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2001;44(8):1782–1785.
  • Kaznowska E, Przybylowska K, Kulig A. The -173 G/C polymorphism of the promoter region macrophage migration inhibitory factor gene is not associated with incidence of pulmonary hamartoma. Pol J Pathol. 2007;58(3):189–192.
  • Gomez LM, Sanchez E, Ruiz-Narvaez EA, Lopez-Nevot MA, Anaya JM, Martin J. Macrophage migration inhibitory factor gene influences the risk of developing tuberculosis in northwestern Colombian population. Tissue Antigens. 2007;70(1):28–33.
  • Prencipe G, Auriti C, Inglese R, et al. A polymorphism in the macrophage migration inhibitory factor promoter is associated with bronchopulmonary dysplasia. Pediatr Res. 2011;69(2):142–147.
  • Chang KC, Leung CC, Tam CM. Tuberculosis risk factors in a silicotic cohort in Hong Kong. Int J Tuberc Lung Dis. 2001;5(2):177–184.